Citation Impact
Citing Papers
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
2012 Standout
Systematic review with meta‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome
2018
On the fiftieth anniversary Postinfectious irritable bowel syndrome: mechanisms related to pathogens
2014
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
2008 Standout
Protein stability promotes evolvability
2006 StandoutNobel
Probiotics, Prebiotics and Antibiotics in the Treatment of Inflammatory Bowel Disease
2012
Psychometric scores and persistence of irritable bowel afterCampylobacter concisusinfection
2014
Patients’ quality of life after laparoscopic or open cholecystectomy
2005
Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions
2010
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome
2012
Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis: results of a multicentre, randomized, placebo‐controlled, cross‐over trial
2002
Characterization of the Gastrointestinal Microbiota in Health and Inflammatory Bowel Disease
2011
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
2011 Standout
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Quality of life in celiac disease patients
2008
Postinfectious Irritable Bowel Syndrome
2009
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Bowel Disorders
2016 Standout
Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review
2011
Ulcerative Colitis
2011 Standout
Long-term outcome 10 years or more after restorative proctocolectomy and ileal pouch–anal anastomosis in patients with ulcerative colitis
2009
New insights into the pathogenesis and pathophysiology of irritable bowel syndrome
2007
Stress and visceral pain: From animal models to clinical therapies
2011
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Crohn's disease
2012 Standout
The Oslo definitions for coeliac disease and related terms
2012 Standout
The rhizosphere microbiome: significance of plant beneficial, plant pathogenic, and human pathogenic microorganisms
2013 Standout
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
2001 Standout
Inflammatory bowel disease: cause and immunobiology
2007 Standout
Probiotics in functional gastrointestinal disorders: what are the facts?
2008
Inflammatory Bowel Disease
2009 Standout
Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery
2010
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
What role do antibiotics have in the treatment of IBD?
2008
Incidence of Post-Infectious Irritable Bowel Syndrome and Functional Intestinal Disorders Following a Water-Borne Viral Gastroenteritis Outbreak
2012
Ulcerative colitis
2012 Standout
Impact of functional gastrointestinal disorders on health‐related quality of life: a population‐based case–control study
2004
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
The Role of Microbes in Crohn's Disease
2006
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
Epidemiology of inflammatory bowel disease
2002
Host microbiota constantly control maturation and function of microglia in the CNS
2015 Standout
Tropical Sprue in 2014: the New Face of an Old Disease
2014
Gastrointestinal infections and the development of irritable bowel syndrome
2011
Health-Related Quality of Life in Patients Attending a Gastroenterology Outpatient Clinic: Functional Disorders Versus Organic Diseases
2006
Prevalence of Uninvestigated Dyspepsia 8 Years After a Large Waterborne Outbreak of Bacterial Dysentery: A Cohort Study
2010
European evidence-based Consensus on the management of ulcerative colitis: Special situations
2008
Intestinal permeability in cirrhotic patients with and without ascites
2005
Ulcerative colitis
2016 Standout
Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter
2011
Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial
2015 Standout
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics
2004
Incidence and Epidemiology of Irritable Bowel Syndrome After a Large Waterborne Outbreak of Bacterial Dysentery
2006
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
2004 Standout
A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease
2004
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Post-Infectious Functional Gastrointestinal Disorders in Children
2008
Brain?Gut?Microbe Communication in Health and Disease
2011
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
AGA technical review on irritable bowel syndrome
2002 Standout
Diversity, stability and resilience of the human gut microbiota
2012 StandoutNature
Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach
2005 Standout
European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations
2006
Design of Treatment Trials for Functional Gastrointestinal Disorders
2016
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis
2008 Standout
Management of Crohn's Disease in Adults
2009 Standout
The pros, cons, and many unknowns of probiotics
2019 Standout
Psychopathology in Irritable Bowel Syndrome: Support for a Psychophysiological Model
2003
The gut microbiota shapes intestinal immune responses during health and disease
2009 Standout
Intestinal microbiota in functional bowel disorders: a Rome foundation report
2012
Irritable Bowel Syndrome
2015 Standout
Gut Microbiota in Health and Disease
2010 Standout
Interventions for providers to promote a patient-centred approach in clinical consultations
2012 Standout
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
The importance of illness perceptions, quality of life and psychological status in patients with ulcerative colitis and Crohn’s disease
2012
Microglia Function in the Central Nervous System During Health and Neurodegeneration
2017 Standout
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
Inflammatory Bowel Disease
2010 Standout
Global Epidemiology of Campylobacter Infection
2015 Standout
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Irritable bowel syndrome: How far do you go in the workup?
2001
The ecology of the microbiome: Networks, competition, and stability
2015 StandoutScience
The oral microbiota: dynamic communities and host interactions
2018 Standout
Design of Treatment Trials for Functional Gastrointestinal Disorders
2006
The microbial basis of inflammatory bowel diseases
2014
Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with non-alcoholic steatohepatitis (NASH)
2016
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout
Works of Mark Borgaonkar being referenced
Quality of life measurement in gastrointestinal and liver disorders
2000
The Incidence of Irritable Bowel Syndrome Among Community Subjects With Previous Acute Enteric Infection
2006
Anti-tuberculous therapy for maintenance of remission in Crohn's disease
1999
Postinfectious Irritable Bowel Syndrome After a Food-Borne Outbreak of Acute Gastroenteritis Attributed to a Viral Pathogen
2007
Putative inflammatory and immunological mechanisms in functional bowel disorders
1999
A meta-analysis of antimycobacterial therapy for Crohn's disease
2000
Providing Disease-Related Information Worsens Health-Related Quality of Life in Inflammatory Bowel Disease
2002